Formulation and Evaluation of a Polyherbal Nanoparticle-Loaded In Situ Ophthalmic Gel Containing Camellia sinensis and Ocimum sanctum

References

[1] Gaudana, R., Ananthula, H. K., Parenky, A., & Mitra, A. K. (2010). Ocular drug delivery. The AAPS Journal, 12(3), 348–360.

[2] Urtti, A. (2006). Challenges and obstacles of ocular pharmacokinetics and drug delivery. Advanced Drug Delivery Reviews, 58(11), 1131–1135.

[3] Ludwig, A. (2005). The use of mucoadhesive polymers in ocular drug delivery. Advanced Drug Delivery Reviews, 57(11), 1595–1639.

[4] Khan, N., & Mukhtar, H. (2007). Tea polyphenols for health promotion. Life Sciences, 81(7), 519–533.

[5] Cabrera, C., Artacho, R., & Giménez, R. (2006). Beneficial effects of green tea. Journal of the American College of Nutrition, 25(2), 79–99.

[6] Yang, C. S., Wang, X., Lu, G., & Picinich, S. C. (2009). Cancer prevention by tea. Annual Review of Nutrition, 29, 19–38.

[7] Prakash, P., & Gupta, N. (2005). Therapeutic uses of Ocimum sanctum. Indian Journal of Physiology and Pharmacology, 49(2), 125–131.

[8] Prakash, K., Mishra, A., & Dubey, V. (2025). Comparative study and qualitative phytochemical screening of different extracts of Psidium guajava leaf. Journal of Pharmaceutical Sciences, 1(11), 160–167.

[9] Prakash, K., & Tiwari, D. (2023). Prospective approaches of herbal novel delivery systems with special reference to herbal nanosciences. Current Drug Therapy, 19. DOI: 10.2174/0115748855269312231110114359.

[10] Prakash, K., & Pandey, D. (2025). Formulation, development and evaluation of HPMC-based hydrogel loaded with Azadirachta indica silver nanoparticles.

[11] Prakash, K., Tiwari, D., & Mishra, V. (2025). Formulation and evaluation of herbal stretch marks reduction cream using Shata Dhauta Ghrit as an API. Acta Scientific Pharmaceutical Sciences, 9, 48–54.

[12] Pandey, D., Lal, B., Prakash, K., & Jaiswal, S. (2025). Formulation and development of HPMC-based hydrogel using silver nanoparticles from Azadirachta indica for antifungal activity. DOI: 10.13140/RG.2.2.27944.69122.

[13] Trease, G. E., & Evans, W. C. (2009). Pharmacognosy (16th ed.). Saunders Elsevier.

[14] Kokate, C. K., Purohit, A. P., & Gokhale, S. B. (2010). Pharmacognosy (45th ed.). Nirali Prakashan.

[15] Aulton, M. E. (2013). Aulton’s Pharmaceutics: The Design and Manufacture of Medicines (4th ed.). Elsevier.

[16] Harborne, J. B. (1998). Phytochemical Methods (3rd ed.). Chapman & Hall.

[17] Handa, S. S., Khanuja, S. P. S., Longo, G., & Rakesh, D. D. (2008). Extraction Technologies for Medicinal and Aromatic Plants. ICS-UNIDO.

[18] World Health Organization (WHO). (1998). Quality Control Methods for Medicinal Plant Materials. WHO Press.

[19] Indian Pharmacopoeia Commission. (2018). Indian Pharmacopoeia. Government of India.

[20] United States Pharmacopeia (USP). (2019). USP-NF. United States Pharmacopeial Convention.

[21] British Pharmacopoeia Commission. (2020). British Pharmacopoeia.

[22] Lin, H. R., & Sung, K. C. (2000). Carbopol-based in situ gel systems for ophthalmic delivery. Journal of Controlled Release, 69(3), 379–388.

[23] Panyam, J., & Labhasetwar, V. (2003). Biodegradable nanoparticles for drug delivery. Advanced Drug Delivery Reviews, 55(3), 329–347.

[24] Draize, J. H., Woodard, G., & Calvery, H. O. (1944). Methods for studying irritation and toxicity. Journal of Pharmacology and Experimental Therapeutics, 82(3), 377–390.

@article{1717609,
      author = {Adarsh Kumar, Arun Kumar, Dr. Amresh Gupta, Hakim Singh Rajput},
      title = {Formulation and Evaluation of a Polyherbal Nanoparticle-Loaded In Situ Ophthalmic Gel Containing Camellia sinensis and Ocimum sanctum},
      journal = {Iconic Research And Engineering Journals},
      year = {2026},
      volume = {9},
      number = {11},
      pages = {654-659},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1717609.pdf},
      abstract = {The present investigation focuses on the development of a novel ocular drug delivery system incorporating herbal extracts of Camellia sinensis and Ocimum sanctum. The study was designed to overcome the limitations associated with conventional ophthalmic preparations such as poor bioavailability and rapid precorneal elimination. Hydroalcoholic extracts of both plants were prepared and characterized for phytochemical constituents. Polymeric nanoparticles were formulated using chitosan and sodium tripolyphosphate through ionic gelation technique. The prepared nanoparticles were further incorporated into a pH-responsive in situ gel system using Carbopol 934 and HPMC K4M. The nanoparticles exhibited nanoscale size distribution with a positive surface charge and satisfactory drug entrapment efficiency. Drug release studies demonstrated a sustained release profile over 12 hours. The in situ gel formulations were evaluated for clarity, pH, viscosity, gelation behavior, drug content, sterility, and ocular irritation. Among the five formulations, F3 showed optimum characteristics, including suitable viscosity, strong gelation, high drug content, and controlled drug release without causing irritation. The developed system successfully combined nanoparticle technology with in situ gelation, resulting in enhanced ocular residence time and improved drug release behavior. This approach offers a promising strategy for delivering polyherbal therapeutics in ocular disorders.},
      keywords = {In-situ Gel, Nanoparticles, Camellia sinensis and Ocimum sanctum},
      month = {May},
      doi = {https://doi.org/10.64388/IREV9I11-1717609}
  }